AAAAAA
Results:
1-7
|
Results: 7
Authors:
KOSTRZEWSKA A
LAUDANSKI T
STEINWALL M
BOSSMAR T
SERRADEILLEGAL C
AKERLUND M
Citation: A. Kostrzewska et al., EFFECTS OF THE VASOPRESSIN V-1A RECEPTOR ANTAGONIST, SR-49059, ON THERESPONSE OF HUMAN UTERINE ARTERIES TO VASOPRESSIN AND OTHER VASOACTIVE SUBSTANCES, Acta obstetricia et gynecologica Scandinavica, 77(1), 1998, pp. 3-7
Authors:
BOSSMAR T
BROUARD R
DOBERL A
AKERLUND M
Citation: T. Bossmar et al., EFFECTS OF SR-49059, AN ORALLY-ACTIVE V1A VASOPRESSIN RECEPTOR ANTAGONIST, ON VASOPRESSIN-INDUCED UTERINE CONTRACTIONS, British journal of obstetrics and gynaecology, 104(4), 1997, pp. 471-477
Authors:
BOSSMAR T
RASMUSSEN T
AKERLUND M
Citation: T. Bossmar et al., EFFECT OF THE NONPEPTIDE, VASOPRESSIN V-1A RECEPTOR ANTAGONIST, SR-49059 AND ITS ENANTIOMER, SR-49770, ON ISOLATED HUMAN MYOMETRIUM, Acta obstetricia et gynecologica Scandinavica, 75(6), 1996, pp. 516-519
Authors:
BOSSMAR T
AKERLUND M
SZAMATOWICZ J
LAUDANSKI T
FANTONI G
MAGGI M
Citation: T. Bossmar et al., RECEPTOR-MEDIATED UTERINE EFFECTS OF VASOPRESSIN AND OXYTOCIN IN NONPREGNANT WOMEN, British journal of obstetrics and gynaecology, 102(11), 1995, pp. 907-912
Authors:
BOSSMAR T
FORSLING M
AKERLUND M
Citation: T. Bossmar et al., CIRCULATING OXYTOCIN AND VASOPRESSIN IS INFLUENCED BY OVARIAN-STEROIDREPLACEMENT IN WOMEN, Acta obstetricia et gynecologica Scandinavica, 74(7), 1995, pp. 544-548
Authors:
CASSLEN B
BOSSMAR T
LECANDER I
ASTEDT B
Citation: B. Casslen et al., PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN BLOOD AND TUMOR FLUIDS OF PATIENTS WITH OVARIAN-CANCER, European journal of cancer, 30A(9), 1994, pp. 1302-1309
Authors:
BOSSMAR T
AKERLUND M
FANTONI G
SZAMATOWICZ J
MELIN P
MAGGI M
Citation: T. Bossmar et al., RECEPTORS FOR AND MYOMETRIAL RESPONSES TO OXYTOCIN AND VASOPRESSIN INPRETERM AND TERM HUMAN-PREGNANCY - EFFECTS OF THE OXYTOCIN ANTAGONISTATOSIBAN, American journal of obstetrics and gynecology, 171(6), 1994, pp. 1634-1642
Risultati:
1-7
|